Oil up will more and more equate to alternatives and efficiencies. As people restrain the over use of a faulty product, with pollution and climate change etc, than the flooding of markets with oil to push demand up doesn't work, and slow the roll out of alternatives and efficiencies fails faster. One huge manipulating power for inflation thus loses their power. From wars around the globe by oil powers driving up debt and destruction, the world can't afford it or the climate change and pollution and living withing our means equates to inflation down and long term investing in America more viable/long bonds.With M2 trending down i look for this to aide the trend and friend as those dollars have to be used more wisely than the present J Biden/J Manchin policy of All of The Above almost as bad

Tough to decide whether or not to short this. I'm going to wait on 360 range then probably short in hopes for the santa claus rally to fade and money managers to move the meta stocks out of their portfolios.Few interviews with their software engineers and they said they were looking to monetize whatsapp by allowing businesses to do business on that app as a big potential money maker, and they still have a major focus on AI and double down on VR/AR metaverse.$META$ Bearish

Even if the Optimus 2 robots become available to work in its own factories in 2024, there is still WAY TOO MUCH DEMAND for the energy that the Tesla MEGAPACK batteries can provide for the robots to assemble and satisfy the need....not for YEARS, even though they are priced over $1,500,000 each and tens of thousands will be produced, with a lot of free labor.....by the ROBOTS annually. The new MegaPack factory in China will put out 10,000 MegaPacks per year, almost all used by China, and the GigaNevada MegaPack factory will be doubled in size to put out 20,000 units-per-year, again, at $1.5million each. That's 45 Billion bucks total revenue that Wall Street is ignoring as if it didn't exist....though they'll provide double the margins than the cars have.$TSLA$ Bullish

4. Before you start to panic and sell PYPL at this price, do your own research and think. So what are the facts about PYPL?1) y/y revenue UP by 7.1%, the number of transactions by 10.2%, total payment volume by 10.8%, EPS by 24.7%2) analysts' price targets after ER with one exception (see below) stay in the range $77 - $110 (I don't count one target $125 by Morgan Stanley as it's clearly unrealistic)3) the lowest price target ($65) was announced by an analyst named David Togut (Evercore), one of the worst ranked analysts with succes rate 50%. Moreover, on 9th July 21 this clown from Evercore raised the price target to $370 from $319, on 2nd Feb 22 he still recommends to BUY with PT $245, as he did in his last "analysis" form 1st Feb 23. And now this expert finally woke up.These "experts" s

The LTIP, currently as stated, the equivalent of 15 M shares have been awarded.  The new request is for another 15 M, or an equivalent total of 30 M shares in the fund.  We know those awards-to-date were and will be awarded at various valuations; for simplicity’s sake using today’s $8/sh valuation the pool’s cost to Shareholders conservatively would be +-$240M when fully awarded.  The first 15 M shares, since the plan’s inception 2018-2021 (2022 outstanding), estimated cost +- $120 M or $30 M per year on average ( the avg PPS during this period was +-$11 not $8).  Where did it go?  What was the headcount in those earlier years, certainly not +-40.  How much income did MARA generate during that period?  Hmmm, appears some accountability is in order. 

$Sidus Space Inc.(SIDU)$CAPE CANAVERAL, Fla. --(BUSINESS WIRE)-- Sidus Space, Inc . (NASDAQ:SIDU), a Space-as-a-Service satellite company focused on mission critical hardware manufacturing; multi-disciplinary engineering services; satellite design, production, launch planning, mission operations; and in-orbit support, is pleased to announce its growing relationship with Teledyne Marine, a part of Teledyne Technologies, Inc. (NYSE:TDY), following a noteworthy Q2 2022. The three-month period marks the strongest revenue quarter between the parties since their partnership began four years ago.

$Amazon.com(AMZN)$AMZN is rapidlyentering the healthcare sector, which was worth $808 billion in the U.S. alone last year, according to one estimate. I believe that, by 2030, Amazon could get 5%-10% of the total healthcare market by getting into the telehealth and prescription markets.Add in some overseas healthcare revenue, and we’re talking about a business that could easily generate $100 billion of annual revenue for AMZN within five years, moving the needle a great deal for the company and its shares.As I’ve noted in previous columns, I believe that Amazon’s new CEO, Andy Jassy, is much “hungrier” for success than his predecessor Jeff Bezos. Consequently, AMZN’s forays into businesses other than the cloud and e-commerce are far more likely to bea

$Amazon.com(AMZN)$AMZN is rapidlyentering the healthcare sector, which was worth $808 billion in the U.S. alone last year, according to one estimate. I believe that, by 2030, Amazon could get 5%-10% of the total healthcare market by getting into the telehealth and prescription markets.Add in some overseas healthcare revenue, and we’re talking about a business that could easily generate $100 billion of annual revenue for AMZN within five years, moving the needle a great deal for the company and its shares.As I’ve noted in previous columns, I believe that Amazon’s new CEO, Andy Jassy, is much “hungrier” for success than his predecessor Jeff Bezos. Consequently, AMZN’s forays into businesses other than the cloud and e-commerce are far more likely to bea

$GameStop(GME)$I would not be too surprised if  Cohen eventually executes a similar head fake with GME stock. He could easily find a way to drive the shares up and then suddenly sell his entire stake, causing all of GameStop’s “meme premium,” if you will, to be erased.GME stock is trading at1.7 times its trailing sales, well above the valuations of other, much more profitable retailers, such asNordstrom(NYSE:JWN), whosetrailing P/S ratiois 0.24 andBest Buy(NYSE:BBY), which has a trailing P/S ratio of 0.37.

$Grab Holdings(GRAB)$ Grab Holdings (NASDAQ:GRAB) is a Singapore-based company that provides ride-hailing and food delivery in a number of Southeast Asian companies. The stock took a hit last week after news emerged that two more executives at the company’s fintech quit. But that’s not all, as Reuters reported that other senior executives have left in recent months too.In other words, the company’s earnings losses are widening. And if a global recession occurs, this will hurt the stock. So, like Abercrombie & Fitch, this one is also among the stocks to avoid.

$Snowflake(SNOW)$ SNOW is a unique stock in the sense Warren Buffettmade a beton its during its highly successful initial public offering, or IPO. Buffett is famously weary of IPOs. The company still counts him as a shareholder and asInvestorPlacecontributor Joel Baglole reports, itscustomer base is growingat a “brisk pace.”

$Sea Ltd(SE)$Primarily, global economic woes impose substantial concerns over SE stock. PerBloomberg, “Shoppers emerging from pandemic lockdowns are cutting back on online purchases, shifting toward essentials during a potential recession.”While the inflationary trend of the U.S. dollar obviously garners the most attention, Sea’s home nation hasn’t been immune. Indeed, anotherBloombergreport last month noted that Singapore’sinflation rate increased 4.4% in Junefrom a year ago. Therefore, the news agency stated that this dynamic bolsters the case for more tightening.

$Sundial Growers Inc.(SNDL)$This company is still very good in my mind, I will look for an opportunity to buy it.

$T2 Biosystems(TTOO)$T2 Biosystems, Inc.(NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced plans to explore the potential to develop a rapid molecular diagnostic test for detection of the monkeypox virus, including technical and commercial feasibility. Monkeypox is a rare disease caused by infection with the monkeypox virus that is part of the orthopoxvirus family of viruses, which also contains smallpox. The main symptom of monkeypox is a rash, but individuals may also present with flu like symptoms. A rapid and accurate diagnosis of monkeypox is essential to expedite treatment and to limit exposure and spread of the disease.

$ChargePoint Holdings Inc.(CHPT)$JPMorgan Chase has an overweight rating on ChargePoint witha price targetof $18. To justify that price, ChargePoint says it will sign deals to charge entire fleets, especially in Europe. My own view is CHPT stock needsa stronger playin the 480 volt market to be worth your investment. Buyers of fast chargers also need to give something for drivers to do with those idle half hours.

$Unity Biotechnology(UBX)$Unity is a very early stage clinical biotech — the opposite of previously mentionedMorphoSys.But its approach seems worthy of a portfolio position. UBX is developing so-called senolytic therapies to treat age-related diseases. These medicines selectively induce the death of senescent cells. Senescent cells are those that have stop dividing. For age-related disorders, this is fertile ground for treatment. By blocking these cells, Unity hopes to halt various age-related diseases.

$Grab Holdings(GRAB)$ This company is still very good in my mind, I will look for an opportunity to buy it.